Prenyltransferase inhibitors: treating human ailments from cancer to parasitic infections
- 27 November 2012
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 4 (3), 476-492
- https://doi.org/10.1039/c2md20299a
Abstract
The posttranslational modification of protein prenylation is a covalent lipid modification on the C-terminus of substrate proteins that serves to enhance membrane affinity. Oncogenic proteins such as Ras have this modification and significant effort has been placed into developing inhibitors of the prenyltransferase enzymes for clinical therapy. In addition to cancer therapy, prenyltransferase inhibitors have begun to find important therapeutic uses in other diseases, including progeria, hepatitis C and D, parasitic infections, and other maladies. This review will trace the evolution of prenyltransferase inhibitors from their initial use as cancer therapeutics to their expanded applications for other diseases.Keywords
This publication has 110 references indexed in Scilit:
- Insights into the Mechanistic Dichotomy of the Protein Farnesyltransferase Peptide Substrates CVIM and CVLSJournal of the American Chemical Society, 2011
- Identification of Novel Peptide Substrates for Protein Farnesyltransferase Reveals Two Substrate Classes with Distinct Sequence SelectivitiesJournal of Molecular Biology, 2010
- A novel approach to tag and identify geranylgeranylated proteinsElectrophoresis, 2009
- Structural Basis for Binding and Selectivity of Antimalarial and Anticancer Ethylenediamine Inhibitors to Protein FarnesyltransferaseCell Chemical Biology, 2009
- Context-Dependent Substrate Recognition by Protein FarnesyltransferaseBiochemistry, 2009
- 2-Oxo-tetrahydro-1,8-naphthyridines as selective inhibitors of malarial protein farnesyltransferase and as anti-malarialsBioorganic & Medicinal Chemistry Letters, 2008
- Treatment with a farnesyltransferase inhibitor improves survival in mice with a Hutchinson–Gilford progeria syndrome mutationBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
- Inhibition of the CaaX proteases Rce1p and Ste24p by peptidyl (acyloxy)methyl ketonesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- Combinatorial Modulation of Protein PrenylationACS Chemical Biology, 2007
- Transition State Analysis of Model and Enzymatic Prenylation ReactionsJournal of the American Chemical Society, 2007